NRIX
Nurix Therapeutics Inc.
Company Overview
| Mkt Cap | $682.69M | Price | $12.94 |
| Volume | 1.68M | Change | +1.25% |
| P/E Ratio | -3.5 | Open | $12.61 |
| Revenue | $54.5M | Prev Close | $12.78 |
| Net Income | $-193.6M | 52W Range | $8.18 - $29.56 |
| Div Yield | N/A | Target | $27.78 |
| Overall | 61 | Value | 60 |
| Quality | 42 | Technical | 83 |
No chart data available
Stock Overview
Updated DailyNurix Therapeutics Inc. (NRIX) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $12.94 with a market capitalization of $682.69 million. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows NRIX with a volume of 1.68 million shares. The stock opened down 1.33% from yesterday's close of $12.78. Current analyst estimates project earnings of $-3.13 per share for this year, with next year targeting $-3.36.
NRIX demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for NRIX include excellent overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 114.7%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 03:51 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NRIX | $12.94 | +1.3% | 1.68M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |